Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study

Thomas Callender and colleagues present a development and validation study using parsimonious ensemble machine learning models to assess eligibility for lung cancer screening.

Related Keywords

United Kingdom ,United States ,Astra Zeneca ,Sujin Kang ,Arjun Nair ,Stephen Duffy ,Mortimer Health ,National Lung Screening Trial ,National Health Service ,National Cancer Institute ,Wellcome ,Bristol Myers Squibb ,Pfizer ,National Science Foundation ,Guardant Health ,Us National Institutes Of Health ,Us National Lung Screening ,Research Council ,Boehringer Ingelheim ,Amgen ,Us National Lung Screening Trial ,Cancer Research United Kingdom ,Us Preventive Services Taskforce ,United Kingdom Biobank ,Lung Screening ,Lung Screening Trial ,Cancer Screening Trial ,Creative Commons Attribution License ,Wellcome Trust ,Medical Research Council ,Merck Sharp ,Lung Cancer Risk Assessment Tool ,Lung Cancer Death Risk Assessment Tool ,Liverpool Lung Project ,Ovarian Cancer Screening Trial ,Services Taskforce ,United Kingdom Biobank Resource ,Lung And Intrathoracic Tumors ,Cancer Risk Factors ,Cancer Screening ,Machine Learning ,Smoking Habits ,Colorectal Cancer ,Forecasting ,Prostate Cancer ,